Reimbursement and adoption of advanced therapies: the 5-C framework

Regen Med. 2014;9(5):573-8. doi: 10.2217/rme.14.51.
No abstract available

Keywords: ATMP; adoption; advanced therapy medicinal product; commercialization; commissioning; cost–effectiveness; health economics; health technology assessment; horizon scanning; pricing; reimbursement.

MeSH terms

  • Cell- and Tissue-Based Therapy / economics
  • Cell- and Tissue-Based Therapy / statistics & numerical data
  • Cell- and Tissue-Based Therapy / trends
  • Costs and Cost Analysis
  • Humans
  • Regenerative Medicine / economics
  • Regenerative Medicine / trends*
  • Reimbursement Mechanisms / trends*
  • Tissue Engineering / economics
  • Tissue Engineering / statistics & numerical data
  • Tissue Engineering / trends